Comparative Effect of Standard Versus Extended Interval Dosing of Rituximab or Ocrelizumab in Multiple Sclerosis

ABSTRACT Objective We aimed to investigate the comparative effectiveness of standard versus personalized extended interval dosing of anti‐CD20 therapy on clinical and sub‐clinical outcomes in multiple sclerosis. Methods Clinical information was collected prospectively on Research Electronic Data Cap...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nabil K. El Ayoubi, Fares Fahd, Hani Tamim, Salem Hannoun, Mark Bal, Elham El‐Hallak, Samia J. Khoury
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-10-01
Serija:	Annals of Clinical and Translational Neurology
Teme:	B‐cell depletion disease outcomes multiple sclerosis
Online dostop:	https://doi.org/10.1002/acn3.70142
Oznake:	Označite Brez oznak, prvi označite!